Fáddáevttohusat
Čájehuvvojit 1 - 20 oktiibuot 77 bohtosis ohcui "Neoplasms therapy."', ohcanáigi: 0,03s Aiddostahte ozu
  1. 1
    Targeting apoptosis pathways in cancer therapy

    Targeting apoptosis pathways in cancer therapy

    Almmustuhtton 2007
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Targeting apoptosis pathways in cancer therapy

    Targeting apoptosis pathways in cancer therapy

    Almmustuhtton 2007
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Therapy in cancer 2008 quo vadis? /

    Therapy in cancer 2008 quo vadis? /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Emerging trends in phase II trial design

    Emerging trends in phase II trial design

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Small molecule inhibitors of receptor tyrosine kinases

    Small molecule inhibitors of receptor tyrosine kinases

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Cytotoxic chemotherapy

    Cytotoxic chemotherapy

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Clinical applications of molecular imaging imaging to guide cancer therapy /

    Clinical applications of molecular imaging imaging to guide cancer therapy /

    Almmustuhtton 2010
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Putting evidence into practice : Improving oncology patient outcomes.

    Putting evidence into practice : Improving oncology patient outcomes.

    Almmustuhtton 2011
    Fáttát:
    Girji
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Putting evidence into practice : Improving oncology patient outcomes /

    Putting evidence into practice : Improving oncology patient outcomes /

    Almmustuhtton 2009
    Fáttát:
    Girji
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    The challenge of targeting toxins to tumors

    The challenge of targeting toxins to tumors

    Almmustuhtton 2007
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Checkpoint blockade in cancer immunotherapy

    Checkpoint blockade in cancer immunotherapy

    Almmustuhtton 2007
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Cancer pain and related symptoms an overview /

    Cancer pain and related symptoms an overview /

    Almmustuhtton 2009
    Fáttát: “…Neoplasms therapy. 112937…”
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Chronic cancer pain the price of success? /

    Chronic cancer pain the price of success? /

    Almmustuhtton 2009
    Fáttát: “…Neoplasms therapy. 112983…”
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    RNA interference and cancer a revolution? /

    RNA interference and cancer a revolution? /

    Almmustuhtton 2007
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Phase III trials

    Phase III trials

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    EGFR inhibitors in NSCLC and the role of biomarkers for selection of patients

    EGFR inhibitors in NSCLC and the role of biomarkers for selection of patients

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Immune checkpoint blockade and head and neck cancer

    Immune checkpoint blockade and head and neck cancer

    Almmustuhtton 2015
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Celiac plexus block

    Celiac plexus block

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Insight and responsibility ethics in pain medicine and palliative care /

    Insight and responsibility ethics in pain medicine and palliative care /

    Almmustuhtton 2009
    Fáttát:
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: